<DOC>
	<DOCNO>NCT02153788</DOCNO>
	<brief_summary>The purpose study test two study drug , one temazepam ( 15mg ) one placebo ( inactive substance look like temazepam ) , see insomnia ( trouble sleep ) reduce patient HIV infection . Placebos give research study try make sure subject respond effect study drug factor , like attention receiving . If decide take part study , take 1 capsule study drug every night approximately 30 minute bedtime approximately 12 week . This study test study drug call temazepam treatment insomnia ( trouble sleep ) patient HIV infection . Temazepam approve FDA treatment insomnia . However , study require treatment 12 week instead 7 10 day approve FDA , use temazepam consider investigational study .</brief_summary>
	<brief_title>Efficacy Safety Temazepam HIV Seropositive Patients With Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Temazepam</mesh_term>
	<criteria>1. male female age 1869 ; 2. female must utilize approved form birth control study ; 3. least 3 month history insomnia define DSMIV criterion primary insomnia ; 4. self report &gt; 60 minute wakefulness initial sleep onset least 4 night 7 consecutive night ; 5. self report &gt; 30 minute selfreported latency sleep onset least 4 night 7 consecutive night ; 6 . Self report &lt; 6.5 hour total sleep time least 4 night 7 consecutive night ; 7. able read , understand , sign inform consent form enter study must willing comply study procedure ; 8. agree participate entire study period ( total approximately 6 month ) ; 9. provide documentation HIV seropositivity enrol ongoing care HIV disease infectious disease clinic last examination exceed 3 month prior screen date 1 . Have clinically significant unstable medical abnormality , history presence significant neurological disorder ( include cognitive disorder ) , frequent nightly urination , define &gt; 2 time per night ; 2 . Had clinically significant illness , determine Investigator , within 30 day Initial Screening ( Visit 1 ) ; 3 . Have clinically significant abnormal find physical examination , neurological assessment , vital sign , determine Investigator ; 4 . Have know exaggerated pharmacological sensitivity hypersensitivity intolerance doxepin HCl , tricyclic antidepressant antihistamine , temazepam benzodiazepine ; 5 . Have positive urine drug screen amphetamine , benzodiazepine , barbiturate , cocaine , opiates , cannabinoids Initial Screening ( Visit 1 ) ; 6 . Self report typical consumption five alcoholic beverage single day great 14 alcoholic beverage weekly ; 7 . Have history epilepsy serious head injury ; 8 . Have current HAART antiretroviral regimen less 1 month ; 9 . Have recent history ( within one year ) alcohol drug abuse , current evidence substance dependence abuse define DSMIVTR criterion ; 10 . Have use temazepam indication within 30 day prior Initial Screening ( Visit 1 ) ; 11 . Have use investigational drug within 30 day five halflives ( whichever longer ) prior Initial Screening ( Visit 1 ) , plan use investigational drug ( study drug ) study ; 12 . Current use follow medication : antipsychotic , appetite suppressant , systemic corticosteroid , theophylline , respiratory stimulant decongestant ; 13 . The following medication may discontinue purpose entry study provide medication take bedtime indication sleep . If indication sleep , medication discontinue purpose entry study : anxiolytic , antidepressant , anticonvulsant , histamine1 receptor antagonist ( except loratadine , desloratidine , fexofenadine ) , narcotic analgesic , sedative/hypnotics ( study drug ) OTC sleep aid ; 14 . Have symptom consistent diagnosis sleep disorder primary insomnia ( e.g. , sleep apnea , narcolepsy , periodic leg movement , restless leg syndrome , etc . ) ; 15 . Have body mass index ( BMI ) great equal 34 ; 16 . Have insomnia associate circadian rhythm disturbance , night rotate shift work travel across four time zone 14 day Initial Screening ( Visit 1 ) study ; 17 . Self report intentional nap two time per week ; 18 . Have variation bedtime three hour five seven consecutive night record sleep diary ; 19 . Have history nonadherence treatment clinical visit attendance ; , 20. subject take benzodiazepine within 5 halflives prior study baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>HIV</keyword>
</DOC>